Over the past 20 years or so, there have been tremendous advances in our understanding of how normal cells transform to diseased/cancer cells and the importance of signaling pathways in cancer initiation and progression. This progress in scientific knowledge has resulted in the development of âpersonalized medicine conceptâ and as a proof-ofconcept, the approval of Gleevec and Herceptin. In addition, technologic advances and the use of high-throughput approaches, particularly in the last 10 years, are beginning to impact our knowledge in genome science and medical technologies. Sayed S Daoud, Hepatitis C Pharmacogenetics: Possible Solutions for an Existing Problem.
Last date updated on September, 2020